Skip to main content
. 2020 Jun 15;12(6):2538–2553.

Figure 6.

Figure 6

LINC01619 promoted tumor cells proliferation and stem cell characteristics in NSCLC via the miR-129-5p/PAX6 axis. A. LINC01619 overexpression inhibited miR-129-5p expression but promoted PAX expression. Conversely, knockdown of LINC01619 increased miR-129-5p expression but decreased PAX6 expression. B. LINC01619 promoted NSCLC cells viability via regulating the miR-129-5p/PAX6 axis. C. LINC01619 enhanced NSCLC cells cloning ability via regulating the miR-129-5p/PAX6 axis. D. LINC01619 increased the sphere number of ALDH+ cells via regulating the miR-129-5p/PAX6 axis. E-G. LINC01619 elevated the mRNA and protein expression of cancer stem cell markers in NSCLC cells via regulating the miR-129-5p/PAX6 axis. *P < 0.05 and **P < 0.01.